Last update 02 Dec 2025

Hema-NeoTIL01

Overview

Basic Info

Drug Type
TIL therapy
Synonyms-
Target-
Action-
Mechanism-
Therapeutic Areas
NeoplasmsImmune System DiseasesHemic and Lymphatic Diseases
Active Indication
Acute Myeloid LeukemiaPrecursor B-Cell Lymphoblastic Leukemia-LymphomaRefractory Acute Leukemia
Inactive Indication-
Originator Organization
The First Affiliated Hospital of Soochow UniversityThe First Affiliated Hospital of Soochow University
Active Organization
The First Affiliated Hospital of Soochow UniversityThe First Affiliated Hospital of Soochow University
Inactive Organization-
License Organization-
Drug Highest PhaseEarly Phase 1
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with Hema-NeoTIL01
NCT06559644
/ Not yet recruitingEarly Phase 1IIT
Assessment of the Safety and Efficacy of Hema-NeoTIL01 Cell Infusion Therapy in Relapsed/Refractory Acute Leukemia: A Single-Arm, Open-Label, Prospective Study
100 Clinical Results associated with Hema-NeoTIL01
Login to view more data
100 Translational Medicine associated with Hema-NeoTIL01
Login to view more data
100 Patents (Medical) associated with Hema-NeoTIL01
Login to view more data
100 Deals associated with Hema-NeoTIL01
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Acute Myeloid LeukemiaPhase 1
China
The First Affiliated Hospital of Soochow UniversityThe First Affiliated Hospital of Soochow University
01 Sep 2024
Precursor B-Cell Lymphoblastic Leukemia-LymphomaPhase 1
China
The First Affiliated Hospital of Soochow UniversityThe First Affiliated Hospital of Soochow University
01 Sep 2024
Refractory Acute LeukemiaPhase 1
China
The First Affiliated Hospital of Soochow UniversityThe First Affiliated Hospital of Soochow University
01 Sep 2024
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free